Morphine increases the activity of midbrain dopamine neurons in vitro

Michael E. Trulson, Kamyar Arasteh

Research output: Contribution to journalArticle

Abstract

Morphine produced a dose-dependent increase in the activity of dopamine-containing neurons in the substantia nigra and ventral tegmental area recorded from mouse brain slices in vitro. The response was not changed in a low calcium/high magnesium incubation medium, indicating that the observed effects are the result of the direct action of morphine on dopamine neurons. Furthermore, a specific opiate antagonist, naloxone, versed the excitatory effects of morphine in both brain regions, while naloxone alone had no significant effect on the activity of dopaminergic neurons. Morphine was more potent on ventral tegmental area than substantia nigra dopamine neurons. β-Endorphin excited ventral tegmental area neurons but not substantia nigra cells, while [Leu5]enkephalin activated cells in both nuclei. These latter responses were blocked by naloxone. These data suggest that midbrain dopamine neurons contain receptors for opiates, and that ventral tegmental area neurons are more sensitive to the action of opiates than substantia nigra neurons.

Original languageEnglish (US)
Pages (from-to)105-109
Number of pages5
JournalEuropean Journal of Pharmacology
Volume114
Issue number1
DOIs
StatePublished - Aug 7 1985

Fingerprint

Dopaminergic Neurons
Mesencephalon
Ventral Tegmental Area
Morphine
Substantia Nigra
Opiate Alkaloids
Naloxone
Neurons
Endorphins
Enkephalins
Midazolam
Brain
Opioid Receptors
Magnesium
In Vitro Techniques
Calcium

Keywords

  • Dopamine
  • In vitro
  • Morphine
  • Single units
  • Substantia nigra
  • Ventral tegmental area

ASJC Scopus subject areas

  • Pharmacology

Cite this

Morphine increases the activity of midbrain dopamine neurons in vitro. / Trulson, Michael E.; Arasteh, Kamyar.

In: European Journal of Pharmacology, Vol. 114, No. 1, 07.08.1985, p. 105-109.

Research output: Contribution to journalArticle

@article{cbaec7ba2e4347f49be956d5601be54f,
title = "Morphine increases the activity of midbrain dopamine neurons in vitro",
abstract = "Morphine produced a dose-dependent increase in the activity of dopamine-containing neurons in the substantia nigra and ventral tegmental area recorded from mouse brain slices in vitro. The response was not changed in a low calcium/high magnesium incubation medium, indicating that the observed effects are the result of the direct action of morphine on dopamine neurons. Furthermore, a specific opiate antagonist, naloxone, versed the excitatory effects of morphine in both brain regions, while naloxone alone had no significant effect on the activity of dopaminergic neurons. Morphine was more potent on ventral tegmental area than substantia nigra dopamine neurons. β-Endorphin excited ventral tegmental area neurons but not substantia nigra cells, while [Leu5]enkephalin activated cells in both nuclei. These latter responses were blocked by naloxone. These data suggest that midbrain dopamine neurons contain receptors for opiates, and that ventral tegmental area neurons are more sensitive to the action of opiates than substantia nigra neurons.",
keywords = "Dopamine, In vitro, Morphine, Single units, Substantia nigra, Ventral tegmental area",
author = "Trulson, {Michael E.} and Kamyar Arasteh",
year = "1985",
month = "8",
day = "7",
doi = "10.1016/0014-2999(85)90530-8",
language = "English (US)",
volume = "114",
pages = "105--109",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Morphine increases the activity of midbrain dopamine neurons in vitro

AU - Trulson, Michael E.

AU - Arasteh, Kamyar

PY - 1985/8/7

Y1 - 1985/8/7

N2 - Morphine produced a dose-dependent increase in the activity of dopamine-containing neurons in the substantia nigra and ventral tegmental area recorded from mouse brain slices in vitro. The response was not changed in a low calcium/high magnesium incubation medium, indicating that the observed effects are the result of the direct action of morphine on dopamine neurons. Furthermore, a specific opiate antagonist, naloxone, versed the excitatory effects of morphine in both brain regions, while naloxone alone had no significant effect on the activity of dopaminergic neurons. Morphine was more potent on ventral tegmental area than substantia nigra dopamine neurons. β-Endorphin excited ventral tegmental area neurons but not substantia nigra cells, while [Leu5]enkephalin activated cells in both nuclei. These latter responses were blocked by naloxone. These data suggest that midbrain dopamine neurons contain receptors for opiates, and that ventral tegmental area neurons are more sensitive to the action of opiates than substantia nigra neurons.

AB - Morphine produced a dose-dependent increase in the activity of dopamine-containing neurons in the substantia nigra and ventral tegmental area recorded from mouse brain slices in vitro. The response was not changed in a low calcium/high magnesium incubation medium, indicating that the observed effects are the result of the direct action of morphine on dopamine neurons. Furthermore, a specific opiate antagonist, naloxone, versed the excitatory effects of morphine in both brain regions, while naloxone alone had no significant effect on the activity of dopaminergic neurons. Morphine was more potent on ventral tegmental area than substantia nigra dopamine neurons. β-Endorphin excited ventral tegmental area neurons but not substantia nigra cells, while [Leu5]enkephalin activated cells in both nuclei. These latter responses were blocked by naloxone. These data suggest that midbrain dopamine neurons contain receptors for opiates, and that ventral tegmental area neurons are more sensitive to the action of opiates than substantia nigra neurons.

KW - Dopamine

KW - In vitro

KW - Morphine

KW - Single units

KW - Substantia nigra

KW - Ventral tegmental area

UR - http://www.scopus.com/inward/record.url?scp=0022181689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022181689&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(85)90530-8

DO - 10.1016/0014-2999(85)90530-8

M3 - Article

C2 - 2931290

AN - SCOPUS:0022181689

VL - 114

SP - 105

EP - 109

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -